SEC
SlamSEC
Search
Browse
Earnings
Metagenomi Therapeutics, Inc.
Nasdaq:
MGX
Biological Products, (No Diagnostic Substances)
·
EMERYVILLE, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
All Filings
(127 total)
Annual Reports
Quarterly Reports
Current Reports
Proxies
Registrations
Insider Activity
Ownership
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13G
SEC STAFF LETTER
UPLOAD
Type
Date
Accession
Period
Size
S-8
Mar 5, 2026
0001193125-26-094014
S-8
—
350.2 KB
10-K
Mar 5, 2026
0001193125-26-093976
10-K
Dec 31, 2025
26.8 MB
8-K
Mar 5, 2026
0001193125-26-093943
8-K
Mar 5, 2026
678.4 KB
8-K
Jan 12, 2026
0001193125-26-009928
8-K
Jan 12, 2026
9.5 MB
4
Dec 8, 2025
0001193125-25-310971
4
Dec 5, 2025
4.7 KB
4
Dec 8, 2025
0001193125-25-310958
4
Dec 5, 2025
4.8 KB
4
Dec 8, 2025
0001193125-25-310953
4
Dec 5, 2025
4.8 KB
4
Dec 8, 2025
0001193125-25-310937
4
Dec 5, 2025
4.8 KB
4
Dec 1, 2025
0001193125-25-304221
4
Sep 5, 2025
4.7 KB
4
Dec 1, 2025
0001193125-25-304218
4
Sep 5, 2025
6.4 KB
4
Dec 1, 2025
0001193125-25-304212
4
Sep 5, 2025
10.6 KB
4
Dec 1, 2025
0001193125-25-304177
4
Sep 5, 2025
6.7 KB
10-Q
Nov 12, 2025
0001193125-25-276150
10-Q
Sep 30, 2025
10.8 MB
8-K
Nov 12, 2025
0001193125-25-276135
8-K
Nov 11, 2025
8.7 MB
8-K
Oct 1, 2025
0001193125-25-226878
8-K
Sep 29, 2025
152.9 KB
144
Sep 11, 2025
0002007317-25-001071
—
4.7 KB
4
Sep 2, 2025
0000950170-25-112535
4
Sep 2, 2025
5.3 KB
3
Aug 15, 2025
0000950170-25-109376
3
Aug 11, 2025
11.8 KB
10-Q
Aug 12, 2025
0000950170-25-107308
10-Q
Jun 30, 2025
9.8 MB
8-K
Aug 12, 2025
0000950170-25-107304
8-K
Aug 12, 2025
15.3 MB
144
Jul 9, 2025
0001968582-25-000580
—
4.8 KB
4
Jun 12, 2025
0000950170-25-085499
4
Jun 10, 2025
5.3 KB
4
Jun 12, 2025
0000950170-25-085488
4
Jun 10, 2025
5.3 KB
4
Jun 12, 2025
0000950170-25-085483
4
Jun 10, 2025
5.3 KB
8-K
Jun 11, 2025
0000950170-25-084529
8-K
Jun 10, 2025
159.9 KB
25 filings shown